Long noncoding RNAs (lncRNAs) participate extensively in biological processes of various cancers. The majority of these transcripts are uniquely expressed in differentiated tissues or specific cancer types. lncRNAs are aberrantly expressed in gliomas and exert diverse functions. In this article, we provided an overview of how lncRNAs regulate cellular processes in glioma, enumerated the lncRNAs that may act as glioma biomarkers, and showed their potential clinical implications. Keywords: long noncoding RNA, glioma, biomarke
Glioma is the commonest form of primary brain tumor in adults with varying malignancy grades and his...
Glioma is the most common malignant central nervous system tumor with significant mortality and morb...
Glioblastoma is the most aggressive and lethal primary brain malignancy, with an average patient sur...
Long non-coding RNAs (LncRNAs) represent a novel class of RNAs with no functional protein-coding abi...
Gliomas are the most common malignancies of the central nervous system. Because of tumor localizatio...
Abstract Glioma is one of the most prevalent types of primary intracranial carcinoma with varying ma...
Gliomas are primary brain tumors presumably derived from glial cells. The WHO grade IV glioblastoma ...
Gliomas are the most common primary brain tumors in adults. Despite the development of multimodal an...
Long noncoding RNAs (lncRNAs) have been implicated in cancer biogenesis and prognosis. However, we s...
Glioma originates in the central nervous system and is classified based on both histological feature...
Glioma is the most common and aggressive tumor of the central nervous system. The uncontrolled proli...
Glioblastoma (GBM) is the most common adult brain tumor and represents one of the most treatment ref...
Each year, over 16,000 patients die from malignant brain cancer in the US. Long noncoding RNAs (lncR...
Dysregulated long noncoding RNAs (lncRNAs) have been found in human diseases, especially in cancer. ...
Accompanying the development of biomedicine, our knowledge of glioma, one of the most common primary...
Glioma is the commonest form of primary brain tumor in adults with varying malignancy grades and his...
Glioma is the most common malignant central nervous system tumor with significant mortality and morb...
Glioblastoma is the most aggressive and lethal primary brain malignancy, with an average patient sur...
Long non-coding RNAs (LncRNAs) represent a novel class of RNAs with no functional protein-coding abi...
Gliomas are the most common malignancies of the central nervous system. Because of tumor localizatio...
Abstract Glioma is one of the most prevalent types of primary intracranial carcinoma with varying ma...
Gliomas are primary brain tumors presumably derived from glial cells. The WHO grade IV glioblastoma ...
Gliomas are the most common primary brain tumors in adults. Despite the development of multimodal an...
Long noncoding RNAs (lncRNAs) have been implicated in cancer biogenesis and prognosis. However, we s...
Glioma originates in the central nervous system and is classified based on both histological feature...
Glioma is the most common and aggressive tumor of the central nervous system. The uncontrolled proli...
Glioblastoma (GBM) is the most common adult brain tumor and represents one of the most treatment ref...
Each year, over 16,000 patients die from malignant brain cancer in the US. Long noncoding RNAs (lncR...
Dysregulated long noncoding RNAs (lncRNAs) have been found in human diseases, especially in cancer. ...
Accompanying the development of biomedicine, our knowledge of glioma, one of the most common primary...
Glioma is the commonest form of primary brain tumor in adults with varying malignancy grades and his...
Glioma is the most common malignant central nervous system tumor with significant mortality and morb...
Glioblastoma is the most aggressive and lethal primary brain malignancy, with an average patient sur...